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Background/aim: This study aimed to evaluate whether NREM-predominant obstructive sleep apnea syndrome (OSAS) patients
(NREM AHI < REM AHI) have distinct clinical and polysomnographic features compared to REM-predominant OSAS patients (REM
AHI > NREM AHI).
Materials and methods: A total of 342 patients (93 females and 249 males) who were admitted to the Sleep Disorders Unit at the Gazi
University Faculty of Medicine and underwent polysomnography between January 2011 and April 2016 were retrospectively reviewed.
Patient data, symptoms related to OSAS, Epworth Sleepiness Scale (ESS) scores, and polysomnographic findings were recorded. The
patients were divided into two groups according to the apnea–hypopnea index (AHI) as patients with NREM-predominant OSAS and
patients with REM-predominant OSAS.
Results: The total AHI in the NREM-predominant group was significantly higher than in the REM-predominant group (P < 0.001). The
patients with severe OSAS constituted the majority in both groups, and the rate of patients with severe OSAS was significantly higher
in the NREM-predominant group than in the REM-predominant group (P < 0.001). Arousal index and sleep time spent under 90%
SaO2 was higher in the NREM-predominant group (P = 0.005, P = 0.001), whereas nocturnal mean and minimum O2 saturation values
were lower in the NREM-predominant group compared to patients with REM-predominant OSAS (P < 0.001, P = 0.013). In evaluating
systemic disorders, the prevalence of coronary artery disease was significantly higher in the NREM-predominant OSAS group (P <
0.001).
Conclusion: Our results showed that patients with NREM-predominant OSAS had a more severe course than patients with REMpredominant OSAS. However, we found no significant difference in sleep-specific symptoms, suggesting that the two groups represented
distinct entities.
Key words: Obstructive sleep apnea, NREM sleep, REM sleep, apnea–hypopnea index, comorbidity

1. Introduction
OSAS affects about 2%–4% of the adult population (1),
resulting in increased morbidity and mortality (2). It is a
risk factor particularly for cardiovascular diseases, such
as systemic arterial hypertension, ischemic heart disease,
stroke, heart failure, and atrial fibrillation (3). As one of
the main symptoms of OSAS, excessive daytime sleepiness
is known to cause cognitive dysfunction, decreased quality
of life, and traffic accidents (4).
Rapid eye movement (REM)-predominant OSAS is a
phenotype of OSAS and its clinical and physiopathological
basis is well understood. In addition, REM-predominant
OSAS has been shown to be associated with female sex,
increased age, and obesity (5). It is known that upper airway
muscle tone decreases more remarkably during REM
sleep compared to non-REM (NREM) sleep. Decreased

muscle tone causes recurrent apnea/hypopnea and deep
hypoxemia episodes at night (6). Several studies have
shown longer apnea episodes, apnea-related desaturation,
and deeper hypoxemia episodes occurring in patients with
REM-predominant OSAS (7,8). Additionally, disturbed
genioglossus reflex response to negative pressure and
decreased chemosensitivity may worsen apnea episodes
during REM sleep (9,10). Therefore, the damage caused
by OSAS is considered to be more severe during REM
sleep than NREM sleep. However, several studies have
reported higher apnea–hypopnea index (AHI) scores
during NREM sleep than during REM sleep. The studies
by Liu et al., Siddiqui et al., and Muraki et al. reported
higher AHI scores in patients with NREM-predominant
OSAS compared to patients with REM-predominant
OSAS (5,11,12). To date, no studies have demonstrated a
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commonly accepted clinical or polysomnographic finding
or a pathological process that could explain the difference
in patients with NREM-predominant OSAS. Based on the
hypothesis that patients with NREM-predominant OSAS
are a distinct patient group, in the present study, we aimed
to evaluate whether NREM-predominant OSAS patients
have distinct clinical and polysomnographic features
compared to REM-predominant OSAS patients.
2. Materials and methods
2.1. Participants and procedures
We retrospectively reviewed the medical records of a
total of 342 patients (93 females and 249 males) who were
admitted to the Sleep Disorders Unit of the Gazi University
Faculty of Medicine due to snoring, apnea, and excessive
daytime sleepiness, who underwent polysomnography
and were diagnosed with OSAS between January 2011
and April 2016. Patients with an AHI score of >5/s were
diagnosed with OSAS; mild OSAS was defined as an
AHI of 5/s–15/s, moderate OSAS was defined as an AHI
of 15/s–30/s, and severe OSAS was defined as an AHI
of higher than 30/s. The patients were administered the
Epworth Sleepiness Scale (ESS) by the physicians and
the symptoms of OSAS were inquired about; the results
and demographic and clinical characteristics of the
patients were recorded. The presence of systemic arterial
hypertension, coronary artery disease, diabetes mellitus,
or gastroesophageal reflux disease commonly occurring
with OSAS was evaluated. Patients who were considered to
have OSAS and those with an ESS score of higher than 10
points underwent polysomnography. Polysomnography
was scored by a single operator to avoid biased results.
During polysomnography, REM and NREM sleep times
and rates, total sleep duration, AI, total AHI, REM AHI,
NREM AHI, mean SaO2, minimum SaO2 measured at
night, sleep time spent under 90% SaO2, sleep induction
time, and sleep times in supine and nonsupine positions
were recorded.
Sleep stages and respiratory events were scored
according to the standard criteria. Apnea was defined as
the cessation of respiratory flow (≥90% drop in respiratory
flow) for at least 10 s; hypopnea was defined as a ≥30%
decrease in respiratory flow for at least 10 s, resulting in
electroencephalographic arousal or 3% or higher decrease
in oxygen saturation (13). Patients with a total sleep time
of less than 240 min in polysomnography, patients with
sleep efficiency of less than 40%, and patients in whom
REM sleep duration was lower than 30 min were excluded.
Patients with a pulmonary disease, central nervous system
disorder, muscle disease, or neuropathy; pregnant women;
patients on sedative drugs; and those who consumed
alcohol were excluded from the study. The patients were
divided into two groups according to the AHI as patients

968

with NREM-predominant OSAS and patients with
REM-predominant OSAS. Clinical characteristics and
polysomnographic data were compared between the two
groups.
2.2. Statistical analysis
Statistical analysis was performed using SPSS 22.0 for
Windows (IBM Corp., Armonk, NY, USA). Numeric data
were expressed as mean ± standard deviation (SD) or
median (min–max), and categorical data were expressed
as number and percentage. Parametric test assumptions
(normality and homogeneity of variance) were tested
before comparing numeric variables between the groups.
When parametric test assumptions were met, two-way
analysis of variance was used to investigate whether there
were differences between patient groups and sexes in terms
of numeric variables. The Mann–Whitney U test was used if
parametric test assumptions were not met. The presence of
a difference in categorical variables between the groups was
investigated using the chi-square test or Fisher’s exact test.
A P-value of 0.05 was considered statistically significant.
3. Results
The patients with NREM-predominant OSAS constituted
45% of the whole study group (154 patients). Males were
the predominant sex both in the REM-predominant (F =
70, M = 118) and NREM-predominant (F = 23, M = 131)
OSAS groups. The mean age of women in the NREMpredominant group was significantly statistically higher
than the mean age of women in the REM-predominant
group (59.5 ± 9.6 years vs. 52.5 ± 9.3 years; P = 0.008.
There was no statistically significant difference between the
median ages of men in the NREM- and REM-predominant
groups (48.6 ± 12.5 years vs. 47.7 ± 10.2 years; P = 0.539).
There were no significant differences in terms of age,
body mass index (BMI), neck circumference, number of
cigarettes smoked per day, or ESS scores between the two
groups. In evaluating systemic disorders, the prevalence
of coronary artery disease was significantly higher in the
NREM-predominant OSAS group (P < 0.001) (Table 1).
The total AHI score in the NREM-predominant group was
significantly higher than in the REM-predominant group
(P < 0.001) (Table 2). Patients with severe OSAS constituted
the majority of the patients in both NREM- and REMpredominant groups, and the rate of patients with severe
OSAS was significantly higher in the NREM-predominant
group than in the REM-predominant group (P < 0.001)
(Figure). When polysomnographic data were evaluated,
AI was higher in the NREM-predominant OSAS group
(P = 0.005). Similarly, nocturnal mean and minimum
SaO2 values were lower in the NREM-predominant group,
whereas sleep time spent under 90% SaO2 was higher
compared to patients with REM-predominant OSAS (P <
0.001, P = 0.013, P = 0.001) (Table 2).
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Table 1. Clinical and baseline characteristics of NREM- and
REM-predominant patients.
NREM
(n = 154)

REM
(n = 188)

P-value

Age (years)

50.2 ± 12.7

49.5 ± 10.1

0.069

Smoking (pack years)

10 [0–90]

3 [0–70]

0.064

BMI (kg/m2)

31.5 ± 6.0

31.8 ± 5.3

0.966

Neck circumference (cm)

43.0 ± 4.1

41.3 ± 3.8

0.409

ESS score

13.6 ± 5.4

12.6 ± 5.5

0.086

Hypertension, n (%)

54 (35.1%)

68 (36.2%)

Coronary artery disease, n (%)

27 (17.5%)

Diabetes mellitus, n (%)

31 (20.1%)

Gastroesophageal reflux, n (%)

47 (30.5%)

Table 2. Polysomnographic data of NREM- and REMpredominant patients.
NREM
(n = 154)

REM
(n = 188)

P-value

NREM1 % of TST

30.6 ± 18.5

16.5 ± 9.5

<0.001

NREM2 % of TST

38.9 ± 10.4

40.5 ± 7.4

0.004

NREM3 % of TST

15.3 ± 12.4

22.7 ± 9.2

<0.001

0.832

REM % of TST

15.8 ± 7.1

20.2 ± 6.5

<0.001

9 (4.8%)

<0.001

AI

33.3 ± 27.0

27.4 ± 16.5

0.005

32 (17%)

0.461

65 (34.6%)

0.427

AHI

41.9 [5.2–137.8]

21.8 [5.1–93.0]

<0.001

AHI REM

18.2 [0–108.3]

47.8 [7.6–100.0]

<0.001

AHI NREM

46.2 [5.3–140.2]

15.9 [0.6–92.6]

<0.001

Mean SaO2 (%)

89.0 ± 5.8

91.1 ± 2.6

<0.001

Minimum SaO2 (%) 75.1 ± 12.8

77.9 ± 9.6

0.013

SaO2 <90% sleep
time spent (min)

29.4 [0–100]

15.5 [0–100]

0.001

Sleep onset (min)

14.8 [1–169]

13.3 [1–100]

0.866

Sleep time in
nonsupine position
(min)

141.8 [19–311.5]

151.8 [0–346.5]

0.988

178.8 [5–349.5]

0.048

NREM: Nonrapid eye movement sleep; REM: rapid eye
movement sleep; n: number of patients; BMI: body mass index;
ESS: Epworth Sleepiness Scale.

When the distribution of common symptoms in
patients with NREM- and REM-predominant OSAS
was compared, no statistically significant difference in
the prevalence of individual symptoms between the two
groups was found (Table 3).
4. Discussion
In our study, we found that the mean AHI score was
significantly higher in the NREM-predominant OSAS
group than in the REM-predominant OSAS group.
Previous studies found no significant difference in the AHI
values of REM and NREM sleep. Several studies reported
no difference in AHI values between REM and NREM
sleep (14,15), whereas other studies reported higher AHI
values in NREM sleep (5,11,12), similar to our results.
We found the prevalence of REM-predominant OSAS
to be 55% in our cohort, which is higher than previously
published data. It was reported that REM-predominant
OSAS varies between 10% and 45% in the OSAS population
(16). We think the reason why the number varies over
such a wide range is the different accepted definitions of
REM-predominant OSAS in the studies. While most of the
studies defined REM-predominant OSAS as an AHI-REM
that was ≥2 times the AHI-NREM, we defined the REMpredominant group as patients with REM AHI > NREM
AHI among the OSAS population.
Men were prevalent in both groups in our study, but
the prevalence of women in the REM-predominant group
was higher than in the NREM-predominant group, which
was similar to the results of the study of Joosten et al.
(17). While they could not explain the different ratios of
women between the groups in their study, we assume that

Sleep time in supine
164.3 [8–318.5]
position (min)

NREM: Nonrapid eye movement sleep; REM: rapid eye
movement sleep; n: number of patients; TST: total sleep time;
AI: arousal index; AHI: apnea–hypopnea index; SaO2: arterial
oxygen saturation. Data are presented as mean ± standard
deviation where values were normally distributed; otherwise,
they are presented as median.
70.00

59.1

60.00
50.00
40.00

31.9

30.00
20.00

26

36.7

31.4

14.90

10.00
0.00

Mild OSA

Moderate OSA

NREM predominant OSA

Severe OSA

REM predominant OSA

Figure. Distribution of NREM- and REM-predominant patients
according to disease severity.
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Table 3. Distribution of common symptoms seen in OSAS for NREM- and REM-predominant patients.
NREM
(n = 154)

REM
(n = 188)

P-value

Habitual snoring, n (%)

152 (98.7%)

188 (100%)

0.202

Witnessed apnea, n (%)

136 (88.3%)

159 (84.6%)

0.400

Daytime sleepiness, n (%)

126 (81.8%)

145 (77.1%)

0.287

Morning headaches, n (%)

66 (42.9%)

99 (52.7%)

0.071

Experiencing behavioral changes, n (%)

45 (29.2%)

56 (29.8%)

0.909

Difficulty adapting to environmental changes, n (%)

33 (21.4%)

49 (26.1%)

0.318

Decrease in decision ability, n (%)

66 (42.9%)

88 (46.8%)

0.465

Having diagnosis of anxiety or depressive disorders, n (%)

34 (22.1%)

44 (23.4%)

0.771

Nocturia, n (%)

94 (61%)

115 (61.2%)

0.980

Diminished libido, n (%)

64 (41.6%)

62 (33%)

0.102

Suffering sleepiness despite adequate night sleep, n (%)

66 (48.5%)

62 (37.6%)

0.056

Motor vehicle accident due to falling asleep, n (%)
Probability of falling asleep during at
least 1 h of motor vehicle travel, n (%)

Probability of falling asleep when stuck
in traffic jam for a few minutes

28 (20.6%)

29 (17.6%)

0.507

Never

20 (13%)

34 (18.1%)

0.394

Rarely

38 (24.7%)

51 (27.1%)

Moderate

60 (39%)

59 (31.4%)

Frequently

36 (23.4%)

44 (23.4%)

Never

54 (35.1%)

86 (45.7%)

Rarely

64 (41.6%)

66 (35.1%)

Moderate

26 (16.9%)

27 (14.4%)

Frequently

10 (6.5%)

9 (4.8%)

0.253

NREM: Nonrapid eye movement sleep; REM: rapid eye movement sleep; n: number of patients.

this difference might be because of hormonal changes,
as women in the NREM-predominant group were more
likely to be menopausal.
When the factors affecting disease severity were
investigated, factors that were found to affect disease
severity in previous studies (5) such as age, BMI, neck
circumference, REM duration, and sleep times in supine/
nonsupine positions did not differ significantly between
the two groups. There were significant differences between
the two groups in terms of nocturnal minimum and mean
SaO2, sleep time spent under 90% SaO2, and AI, which
could affect disease severity. The findings of significantly
lower nocturnal mean and minimum SaO2 and longer sleep
time spent under 90% SaO2 in the NREM-predominant
OSAS group when compared to the REM-predominant
OSAS group are consistent with the reports by Liu et al.
and Siddiqui et al. (5,11). Siddiqui et al. attributed lower
nocturnal oxygen saturation values in NREM sleep to
longer sleep apnea times (5). The finding of higher AI in
the NREM-predominant group was consistent with the
findings of Verginis et al., who reported on older children
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with OSAS (18). Yamauchi et al. similarly found a higher
AI in patients with NREM-predominant OSAS; they
considered this as another factor contributing to disease
severity (19). They suggested that irregular respiratory
patterns caused by arousal in patients who possibly have
low arousal thresholds might have resulted in more
dynamic changes in PaCO2 due to high loop gain; this
may have in turn caused recurrent apnea and hypopnea
episodes (19). In support of this hypothesis, Terrill et al.
concluded that patients with NREM-predominant OSAS
have higher loop gain (20). The authors of the present
study also suggest that this could be the reason for more
severe disease in the NREM-predominant OSAS group.
The present study also found higher prevalence
of coronary artery disease in patients with NREMpredominant OSAS. We were unable to locate any literature
data supporting our findings on patients with NREMpredominant OSAS. The increased arousal index found
in NREM sleep causes intermittent hypoxia. Previous
studies have suggested that increased sympathetic activity
caused by intermittent hypoxia increases the risk of
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developing coronary artery disease by causing arousalrelated tachycardia and increased left ventricular afterload,
endothelial dysfunction, and systemic inflammation
(3). In the present study, it was suggested that increased
prevalence of coronary artery disease in patients with
NREM-predominant OSAS may be caused by increased
AI.
Although the present study found significant
differences between REM- and NREM-predominant OSAS
groups in terms of disease severity and polysomnographic
features, there was no significant difference in terms of
sleep-related symptoms and ESS scores. The ESS is a
simple and easily applied test used in disease screening;
however, its inability to measure disease severity due to its
lower sensitivity and specificity may be the reason for not
finding any significant difference in ESS scores between
the groups (21). The differences in terms of sleep-related
symptoms could be more accurately evaluated using
detailed and objective sleep, quality of life, and depression
scales and tests. The inability of the present study to find

a significant difference in terms of clinical symptoms may
be caused by the fact that we did not use detailed tests and
scales; this is one of the limitations of the present study.
Another limitation of this study is that we did not include
duration of apnea episodes during NREM and REM sleep,
which were suggested to affect disease severity in previous
studies.
In conclusion, the disease has a more severe course
in patients with NREM-predominant OSAS. Higher AI
and lower SaO2 values in the present study seem to be
related to more severe disease in patients with NREMpredominant OSAS. The lack of difference between the
two groups in terms of sleep-specific symptoms precludes
us from determining that NREM-predominant OSAS is
a distinct clinical entity from REM-predominant OSAS.
More detailed studies on the subgroups of OSAS must be
designed in the future that consider the factors in detail
that cause more severe disease and that measure sleep,
depression, and quality of life using tests and scales.
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